dianhydrogalactitol has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Görlich, M; Heise, E; Kerpel-Fronius, S; Számel, I | 1 |
| Andersen, J; Frei, E; Furlong, EA; Henner, WD; Kelley, SL; Peters, WP | 1 |
2 other study(ies) available for dianhydrogalactitol and Carcinoma
| Article | Year |
|---|---|
Chemotherapeutic agents and estradiol receptor binding capacity.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Dianhydrogalactitol; Estradiol; Female; Fluorouracil; Humans; In Vitro Techniques; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mechlorethamine; Nafoxidine; Rats; Receptors, Estrogen; Tamoxifen; Uterus | 1979 |
Pharmacokinetics of dibromodulcitol in humans: a phase I study.
Topics: Absorption; Administration, Oral; Adult; Aged; Bone Marrow Transplantation; Carcinoma; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Half-Life; Humans; Kinetics; Male; Melanoma; Middle Aged; Mitolactol; Neoplasm Metastasis; Sarcoma; Time Factors | 1986 |